PATENT CLAIM ANALYSIS

Application Number: 15988965
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["514", "510000"]

Abstract:
The present specification provides RXR agonist compounds, compositions comprising such RXR agonists, and methods using such compounds and compositions to treat an autoimmune disorder, inflammation associated with an autoimmune disorder and/or a transplant rejection as well as use of such RXR agonists to manufacture a medicament and use of such compounds and compositions to treat an autoimmune disorder, inflammation associated with an autoimmune disorder and/or a transplant rejection.

Claim (Index 12):
The method according to  claim 1 , wherein the therapeutically effective amount is about 0.001 mg/kg/day to about 100 mg/kg/day.

Metadata:
- Claim Count in Document: 45.0
- Percentile: 93.0
- Lexical Diversity: 2.14706
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15341969', '15852580', '14507730', '14626339', '15812821']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7963272882908622
- 35 USC 102 Novelty (BERT): 0.5973850475237699
- Combined Prediction Score: 0.7764330642141529
- Mean Citation Score: 440.915416
- Max Citation Score: 510.4197
- Similarity Product: 449.1439604631186

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test